Table 2.
Laboratory findings and in-hospital mortality of 1731 study patients.
| Variables | Group 1 (n = 1055)a | Group 2 (n = 519)a | Group 3 (n = 157)a | p valueb |
|---|---|---|---|---|
| Total cholesterol level (mg/dL) | 177.6A ± 41.7 | 175.5A ± 43.2 | 161.7B ± 39.1 | <0.0001 |
| Low-density lipoprotein | 105.6A ± 36.6 | 106.3A ± 35.0 | 95.2B ± 34.4 | 0.002 |
| White blood cell count (×103)/mL | 9.8 ± 25.1 | 8.2 ± 3.4 | 8.6 ± 3.2 | 0.846 |
| Neutrophil (N) (%) | 65.2A ± 11.5 | 68.2B ± 11.8 | 71.2C ± 12.8 | <0.0001 |
| Lymphocyte (L) (%) | 26.2A ± 10.0 | 25.2A ± 29.6 | 20.9B ± 11.3 | 0.003 |
| Monocyte (M) (%) | 6.1 ± 4.7 | 5.8 ± 2.4 | 5.9 ± 2.3 | 0.413 |
| Platelet (P) count (×104)/mL | 213.0 ± 111.7 | 213.8 ± 75.8 | 211.5 ± 90.9 | 0.969 |
| Ratio of N to L | 3.5A ± 4.3 | 4.4B ± 6.7 | 5.9C ± 7.6 | <0.0001 |
| Ratio of N to M | 13.8 ± 12.3 | 16.7 ± 42.9 | 15.4 ± 13.2 | 0.113 |
| Ratio of P to S | 3.34 ± 1.59 | 3.24 ± 1.28 | 3.06 ± 1.40 | 0.054 |
| Hemoglobin (g/dL) | 13.6A ± 4.6 | 13.3A,B ± 2.2 | 12.7A ± 2.3 | 0.014 |
| Creatinine (mg/dL) | 1.6 ± 5.1 | 1.7 ± 2.3 | 1.2 ± 1.3 | 0.058 |
| eGFR (mL/min/1.73 m2) | 70.5 ± 29.7 | 66.7 ± 32.7 | 70.8 ± 33.4 | 0.512 |
| In-hospital mortality | 2.0% (21) | 3.1% (16) | 14.0% (22) | <0.0001 |
Data are expressed as mean ± S.D. or % (n).
Abbreviation: eGFR: estimated glomerular filtration rate.
a
Group 1 = patients with National Institute of Health Stroke Scale (NIHSS) <6.0. Group 2 = patients with NIHSS ≥6.0 and <16.0. Group 3 = patients with NIHSS >16.0.
b
Indicated continuous data were analyzed using one-way ANOVA, and categorical data were analyzed by chi-square test. Different letters (A, B, C) indicated significant difference (at 0.05 level) by Tukey's multiple comparison procedure.